April 2025 – CROSS Research SA and DERMING srl are pleased to announce the finalization of a Joint Venture agreement for the conduct of clinical studies in the dermatological field involving drugs, medical devices and advanced dermo-cosmetic products.
CROSS Research SA is a private, Swiss, Contract Research Organization (CRO) active in the field of clinical drug development since 1997.
CROSS Research work is performed in full compliance with GCP procedures, as certified by local Authorities (Canton Ticino) the Swiss Confederation Health Authority (Swissmedic) and assessed by different CA Inspections and Sponsor audits.
CROSS has performed several clinical trials in the dermatological field supported by more than a decade of experience and documented through various published scientific papers: https://www.croalliance.com/expertise/#dermatology).
DERMING srl is committed to evaluating both the tolerability and efficacy of products designed for skin contact (cosmetics, pharmaceuticals, and medical devices).
The company has developed a range of advanced assessment methodologies and is renowned for the quality of its clinical studies and the prestige of its scientific publications.
Over the years, DERMING has conducted studies and provided consultancy services in the medical-dermatological field on behalf of leading companies in the pharmaceutical and medical-aesthetic sectors.
Thanks to this new collaboration, CROSS and DERMING are now able to offer a comprehensive range of services to companies seeking to validate the performance of their medical devices through clinical studies, or to assess the safety, efficacy, and tolerability of their pharmaceutical products.
Adele Sparavigna, Founder of DERMING stated: “With the regulated GCP environment that CROSS grants we can really provide a great and competitive support in this complex field”
Riccardo Assandri, CROSS’ Corporate Manager added: “With this agreement we can rely on the wide experience and the relevant scientific background of Dr. Adele Sparavigna in the dermatological field and offer a large panel of up-to-date solutions to our customers”.